This article was downloaded by: [Dr Jessica Potter] On: 20 August 2015, At: 07:21 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: 5 Howick Place, London, SW1P 1WG Click for updates Ocular Immunology and Inflammation Publication details, including instructions for authors and subscription information: http:/ / www.tandfonline.com/ loi/ ioii20 Moxifloxacin: An Alternative to Ethambutol for the Treatment of Presumed Ocular Tuberculosis Jessica Pot t er BA, MBBCh a , Rupesh Agrawal FRCS, MMed, DNB bcd , Claire Barraclough BSc a , Farzana Rahman BSc, FRCophth b , Mark Westcott FRCOphth b , Carlos E. Pavesio FRCOphth bc & Veronica Whit e BSc, MBBS, MS, MD a a Barts Health NHS Trust, TB Service, London, UK, b Moorfields Eye Hospital, NHS Foundation Trust, London, UK, c Biomedical Research Centre, UCL Institute of Ophthalmology, London, UK, and d National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore Published online: 19 Aug 2015. To cite this article: Jessica Potter BA, MBBCh, Rupesh Agrawal FRCS, MMed, DNB, Claire Barraclough BSc, Farzana Rahman BSc, FRCophth, Mark Westcott FRCOphth, Carlos E. Pavesio FRCOphth & Veronica White BSc, MBBS, MS, MD (2015): Moxifloxacin: An Alternative to Ethambutol for the Treatment of Presumed Ocular Tuberculosis, Ocular Immunology and Inflammation To link to this article: ht t p:/ / dx.doi.org/ 10.3109/ 09273948.2015.1019155 PLEASE SCROLL DOWN FOR ARTICLE Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in the publications on our platform. However, Taylor & Francis, our agents, and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor and Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to or arising out of the use of the Content. This article may be used for research, teaching, and private study purposes. Any substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in any form to anyone is expressly forbidden. Terms & Conditions of access and use can be found at http:// www.tandfonline.com/page/terms-and-conditions